NCT06399172View on ClinicalTrials.gov

OncoSil Pancreatic Cancer Post-marketing Clinical Registry - Italy

Not yet recruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

May 30, 2024

Primary Completion Date

May 30, 2029

Study Completion Date

October 30, 2029

Conditions
Locally Advanced Pancreatic Adenocarcinoma
Interventions
DEVICE

OncoSil

Intra-tumoural implantation

Sponsors
All Listed Sponsors
lead

OncoSil Medical Limited

INDUSTRY

NCT06399172 - OncoSil Pancreatic Cancer Post-marketing Clinical Registry - Italy | Biotech Hunter | Biotech Hunter